Following an initial phase in which the dose of the drug was gradually increased in patients, 72 patients
enrolled in the second phase, in which two doses were tested at different administration schedules — weekly, twice monthly, and monthly — for up to two years.
Not exact matches
The
second phase began
in 2014 and
enrolled children up to 3 years old, also with mild to profound bilateral hearing loss.
Finch expects to begin
enrolling for a
Phase II clinical trial to evaluate the safety and efficacy of FIN - 403 for the prevention of recurrence
in recurrent C. difficile patients
in the
second half of 2017.
«These survey results have shown us there's increased confidence among Baby Boomers
in their ability to achieve their goals
in their next
phase of life — which might mean starting a
second career,
enrolling in college classes, trying Zumba and acting classes or mentoring kids at the local elementary school.»